Platelet Function and Serum High Density Lipoproteins

Summary

Two groups of healthy male subjects one with low (mean 1.03 mmol/1), and the other with normal (mean 1.80 mmol/1), concentrations of high density lipoprotein (HDL) cholesterol in plasma were investigated. A series of in vitro platelet function tests were performed in order to investigate a possible connection between low HDL concentration, which has been defined as an independent risk factor for the occurrence of CHD, and disturbances in platelet function.

No significant differences in platelet function were observed between the two groups. A positive correlation was found between platelet factor 3 activity both in platelet rich and platelet poor plasma and the plasma concentration of HDL.

• References

• 1 Ali M, Mcdonald JW D. 1977; Effects of sulfinpyrazone on platelet prostaglandin synthesis and platelet release of serotonin. Journal of Laboratory and Clinical Medicine 89: 868
• 2 Baker K, Joist JH, Kay DM, Schonfeld G. 1976; Increased platelet function in hyperlipoproteinemia?. Circulation (abstr.) 53 (11) 116
• 3 Born GV R. 1962; Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature 194: 927
• 4 Bruyere DeM, Bellenot C, Sokal G. 1974; Electronic platelet counting after isopycnic differential centrifugation. A simple rapid and accurate method. Thrombosis et Diathesis Haemor- rhagica 32: 232
• 5 Burstein M, Scholnik HR, Morfin R. 1970; Rapid method for the isolation of lipoproteins from human serum by precipitation with polyanions. Journal of Lipid Research 11: 583
• 6 Carvalho AC A, Colman RW, Lees RS. 1974; Platelet function in hyperlipoproteinemia. New England Journal of Medicine 290: 434
• 7 Colman RW. 1978; Platelet function in hyperbetalipoproteinemia. Thrombosis et Haemostasis 39: 284
• 8 Gordon T, Castelli WP, Hjortland MC, Kannel WB, Dawber TR. 1977; High density Lipoprotein as a protective factor against coronary heart disease. American Journal of Medicine 62: 707
• 9 Miller NE, Førde OH, Thelle D, Mjøs OD. 1977; High density lipoprotein and coronary heart disease: A prospective case control study. Lancet 1: 965
• 10 Lowry HO, Rosebrough NJ, Lewis Farr A, Randall RJ. 1951; Protein measurements with the folin phenol reagent. Journal of Biological Chemistry 193: 265
• 11 Ludlam CA, Moore S, Bolton AE, Pepper DS, Cash JD. 1975; The release of a human platelet specific protein measured by a radioimmunoassay. Thrombosis Research 6: 543
• 12 Miller ME, Nordø A. 1977; Effects of human plasma lipoproteins on platelet aggregation and platelet factor 3 activity in vitro. Atherosclerosis 28: 181
• 13 Mjøs OD, Thelle DS, Forde OH, Vik-Mo H. 1977; Family study of high density lipoprotein cholesterol and the relation to age and sex. Acta Medica Scandinavica 201: 323
• 14 Nordøy A, Rodset JM. 1971; Platelet function and platelet phospholipids in patients with hyperbetalipoproteinemia: effect of nicotinic acid and clofibrate. Acta Medica Scandinavica 189: 385
• 15 Nordøy A, Strøm E, Gjesdal K. 1974; The effect of alimentary hyperlipaemia and primary hypertriglyceridaemia on platelets in man. Scandinavian Journal of Haematology 12: 329
• 16 Nordøy A, Svensson B, Wiebe P, Hoak JC. 1978; Lipoproteins and the inhibitory effect of human endothelial cells on platelet function. Circulation Research 43: 527
• 17 Sandberg H, Andersson LO. 1979 A highly sensitive assay of platelet factor 3 using a chromogenic substrate. Thrombosis Research. in press
• 18 Sandberg H, Andersson LO. 1976; Studies on the thromboplastic effect of human plasma lipoproteins. Thrombosis et Haemostasis 35: 178
• 19 Smith JB, Ingerman CM, Kocsis JJ, Silver MJ. 1974; Formation of an intermediate in prostaglandin biosynthesis and its association with the platelet release reaction. The Journal of Clinical Investigation 53: 1468
• 20 Smith JB, Ingerman CM, Silver MJ. 1976; Malondialdehyde formation as an indicator of prostaglandin production by human platelets. Journal of Laboratory and Clinical Medicine 88: 167
• 21 Wu KK, Hoak JC. 1974; A new method for the quantitative detection of platelet aggregates in patients with arterial insufficiency. Lancet 2: 924